These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23233628)

  • 21. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation.
    Sperzel M; Huetter J
    J Thromb Haemost; 2007 Oct; 5(10):2113-8. PubMed ID: 17666018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy.
    Brenni M; Worn M; Brüesch M; Spahn DR; Ganter MT
    Acta Anaesthesiol Scand; 2010 Jan; 54(1):111-7. PubMed ID: 19860752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic options for perioperatively acquired platelet dysfunctions].
    Weber CF; Schneider AC; Kirschning T; Hofstetter C; Zacharowski K; Görlinger K
    Anaesthesist; 2009 Sep; 58(9):931-2, 934-6, 938-40. PubMed ID: 19727578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemostatic drugs.
    Mannucci PM
    N Engl J Med; 1998 Jul; 339(4):245-53. PubMed ID: 9673304
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemostatic changes in extracorporeal surgery: pathogenesis and treatment].
    Páramo JA; Rifón J; Rocha E
    Sangre (Barc); 1993 Jun; 38(3):225-31. PubMed ID: 8211549
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of aprotinin and tranexamic acid on fibrinolysis and thrombin generation during cardiopulmonary bypass].
    Risch A; Dorscheid E; Stein G; Seyfert UT; Grundmann U
    Anaesthesist; 2000 Apr; 49(4):279-85. PubMed ID: 10840537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombotic reversal agents.
    Wilson MD; Davis JE
    Emerg Med Clin North Am; 2014 Aug; 32(3):715-25. PubMed ID: 25060258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
    Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
    Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure.
    Mezzano D; Panes O; Muñoz B; Pais E; Tagle R; González F; Mezzano S; Barriga F; Pereira J
    Thromb Haemost; 1999 Oct; 82(4):1250-4. PubMed ID: 10544908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation.
    Despotis GJ; Avidan MS; Hogue CW
    Ann Thorac Surg; 2001 Nov; 72(5):S1821-31. PubMed ID: 11722116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Indications for the use of platelets, plasma and anti-hemorrhagic drugs].
    Mateo J; Muñiz-Díaz E; Fontcuberta J; Madoz P
    Rev Esp Anestesiol Reanim; 1992; 39(6):355-61. PubMed ID: 1293653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulation factor concentrate-based therapy for remote damage control resuscitation (RDCR): a reasonable alternative?
    Maegele M
    Transfusion; 2016 Apr; 56 Suppl 2():S157-65. PubMed ID: 27100752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM
    Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reversal for heparins and new anticoagulant treatments].
    Kortchinsky T; Vigué B; Samama CM
    Ann Fr Anesth Reanim; 2013 Jan; 32(1):37-49. PubMed ID: 23273505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
    Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
    Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative use of modified thrombelastography in factor XI deficiency: a helpful method to assess drug effects.
    Dirkmann D; Hanke AA; Görlinger K; Peters J
    Acta Anaesthesiol Scand; 2007 May; 51(5):640-3. PubMed ID: 17430330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations.
    Webster K; Wilde J
    Br J Oral Maxillofac Surg; 2000 Apr; 38(2):124-6. PubMed ID: 10864707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.